LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS

LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS was reported 84 times

LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARADOXICAL EMBOLISM 1 0.0093
1 RETINAL DYSTROPHY 1 0.0042
2 GUTTATE PSORIASIS 1 0.0012
3 PERITONSILLAR ABSCESS 1 0.0012
4 SLEEP-RELATED EATING DISORDER 1 0.0011
5 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
6 PERIPHERAL ARTERY OCCLUSION 1 0.0007
7 PELVIC VENOUS THROMBOSIS 1 0.0007
8 PREGNANCY ON CONTRACEPTIVE 1 0.0007
9 EMBOLISM VENOUS 2 0.0007
10 AGE-RELATED MACULAR DEGENERATION 1 0.0007
11 INTERMENSTRUAL BLEEDING 3 0.0005
12 PREGNANCY ON ORAL CONTRACEPTIVE 1 0.0004
13 MACULOPATHY 1 0.0003
14 APPENDICECTOMY 1 0.0003
15 PERIPHERAL ISCHAEMIA 1 0.0002
16 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
17 HIP SURGERY 1 0.0002
18 CYSTIC FIBROSIS 1 0.0002
19 STREPTOCOCCAL INFECTION 1 0.0002
20 METRORRHAGIA 3 0.0002
21 PLEURISY 1 0.0002
22 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
23 PRE-EXISTING CONDITION IMPROVED 1 0.0002
24 SOMNAMBULISM 1 0.0002
25 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
26 RESPIRATION ABNORMAL 1 0.0001
27 LYMPHOEDEMA 1 0.0001
28 PANIC REACTION 1 0.0001
29 PRODUCT PRESCRIBING ISSUE 3 0.0001
30 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
31 APNOEA 1 0.0001
32 GASTROINTESTINAL INFLAMMATION 1 0.0001
33 MULTIPLE ALLERGIES 1 0.0001
34 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
35 FURUNCLE 1 0.0001
36 FACIAL PARALYSIS 1 0.0001
37 MENSTRUATION IRREGULAR 3 0.0001
38 VITAMIN D DEFICIENCY 1 0.0001
39 INFLAMMATORY BOWEL DISEASE 1 0.0001
40 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
41 MICTURITION URGENCY 1 0.0001
42 JOINT RANGE OF MOTION DECREASED 1 0.0001
43 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
44 PRODUCT SUBSTITUTION ISSUE 4 0.0001
45 BLOOD COUNT ABNORMAL 1 0.0001
46 DRUG DISPENSING ERROR 1 0.0001
47 PHARYNGEAL OEDEMA 1 0.0001
48 DEEP VEIN THROMBOSIS 4 0.0001
49 PHOTOSENSITIVITY REACTION 1 0.0001
50 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
51 GASTRIC DISORDER 2 0.0001
52 AMENORRHOEA 1 0.0001
53 THINKING ABNORMAL 1 0.0001
54 PHOTOPHOBIA 1 0.0001
55 SLEEP APNOEA SYNDROME 1 0.0001
56 INCREASED APPETITE 1 0.0001
57 HERNIA 1 0.0001
58 HAEMORRHOIDS 1 0.0001
59 SKIN FISSURES 1 0.0001
60 KIDNEY INFECTION 1 0.0001
61 DISABILITY 1 0.0001
62 PSORIATIC ARTHROPATHY 2 0.0000
63 BLINDNESS 2 0.0000
64 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
65 FIBROMYALGIA 1 0.0000
66 CEREBRAL INFARCTION 1 0.0000
67 DRY EYE 2 0.0000
68 RASH GENERALISED 1 0.0000
69 DERMATITIS ATOPIC 2 0.0000
70 MOOD ALTERED 1 0.0000
71 LIMB DISCOMFORT 1 0.0000
72 FEMUR FRACTURE 1 0.0000
73 PULMONARY EMBOLISM 3 0.0000
74 MIGRAINE 3 0.0000
75 PRODUCT DOSE OMISSION 2 0.0000
76 PSORIASIS 4 0.0000
77 STAPHYLOCOCCAL INFECTION 1 0.0000
78 VISUAL ACUITY REDUCED 1 0.0000
79 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
80 HEART RATE DECREASED 1 0.0000
81 DYSARTHRIA 1 0.0000
82 EXTRA DOSE ADMINISTERED 1 0.0000
83 TINNITUS 1 0.0000
84 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
85 BLOOD CHOLESTEROL INCREASED 1 0.0000
86 DISEASE RECURRENCE 1 0.0000
87 AGGRESSION 1 0.0000
88 SINUSITIS 2 0.0000
89 SEIZURE 2 0.0000
90 WHEEZING 1 0.0000
91 INJECTION SITE PRURITUS 1 0.0000
92 PRODUCT QUALITY ISSUE 2 0.0000
93 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
94 COUGH 4 0.0000
95 SKIN BURNING SENSATION 1 0.0000
96 MOBILITY DECREASED 1 0.0000
97 CONSTIPATION 3 0.0000
98 BRONCHITIS 1 0.0000
99 HYPOAESTHESIA 2 0.0000
100 ACNE 1 0.0000
101 INJECTION SITE SWELLING 1 0.0000
102 HOSPITALISATION 2 0.0000
103 INJECTION SITE BRUISING 1 0.0000
104 INTENTIONAL PRODUCT MISUSE 1 0.0000
105 MUSCULOSKELETAL STIFFNESS 1 0.0000
106 TACHYCARDIA 1 0.0000
107 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
108 GASTROINTESTINAL DISORDER 1 0.0000
109 NO ADVERSE EVENT 2 0.0000
110 MUSCLE SPASMS 2 0.0000
111 OROPHARYNGEAL PAIN 1 0.0000
112 HYPERSENSITIVITY 2 0.0000
113 CONTUSION 1 0.0000
114 ATRIAL FIBRILLATION 1 0.0000
115 HEART RATE INCREASED 1 0.0000
116 CONDITION AGGRAVATED 3 0.0000
117 FLUSHING 1 0.0000
118 ABDOMINAL PAIN UPPER 2 0.0000
119 ILLNESS 1 0.0000
120 FALL 3 0.0000
121 WEIGHT INCREASED 2 0.0000
122 DEPRESSION 2 0.0000
123 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
124 ABDOMINAL PAIN 2 0.0000
125 PALPITATIONS 1 0.0000
126 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
127 INJECTION SITE ERYTHEMA 1 0.0000
128 HYPERHIDROSIS 1 0.0000
129 INSOMNIA 2 0.0000
130 NEUTROPENIA 1 0.0000
131 VISION BLURRED 1 0.0000
132 MALAISE 3 0.0000
133 INJECTION SITE PAIN 2 0.0000
134 PARAESTHESIA 1 0.0000
135 PNEUMONIA 2 0.0000
136 DRUG INEFFECTIVE 8 0.0000
137 ABDOMINAL DISCOMFORT 1 0.0000
138 URINARY TRACT INFECTION 1 0.0000
139 COVID-19 1 0.0000
140 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
141 CHEST PAIN 1 0.0000
142 PRODUCT USE ISSUE 1 0.0000
143 BLOOD GLUCOSE INCREASED 1 0.0000
144 ANAEMIA 1 0.0000
145 PRURITUS 2 0.0000
146 FATIGUE 4 0.0000
147 SOMNOLENCE 1 0.0000
148 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
149 DIARRHOEA 3 0.0000
150 OFF LABEL USE 4 0.0000
151 INCORRECT DOSE ADMINISTERED 1 0.0000
152 BACK PAIN 1 0.0000
153 VOMITING 2 0.0000
154 FEELING ABNORMAL 1 0.0000
155 WEIGHT DECREASED 1 0.0000
156 PRODUCT DOSE OMISSION ISSUE 1 0.0000
157 PAIN 2 0.0000
158 HEADACHE 2 0.0000
159 NAUSEA 2 0.0000
160 ARTHRALGIA 1 0.0000
161 RASH 1 0.0000
162 DYSPNOEA 1 0.0000
163 DEATH 1 0.0000